← FDA Drug Approvals (Drugs@FDA)

ENTYVIO

BLA · Biologics License Application · Sponsor: TAKEDA PHARMS USA · Approved 2024-04-18

Drug application

FDA Application #

BLA761359

Application type

Biologics License Application

Brand name

ENTYVIO

Generic name

Vedolizumab

Active ingredients

VEDOLIZUMAB

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

TAKEDA PHARMS USA

First approval

2024-04-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown